VeriMomoligopeptide-55 est-il sûr pendant la grossesse ?
No harmonised CLP classification, no SCCS or CIR safety assessment specific to oligopeptide-55, and no peer-reviewed reproductive or developmental toxicity data located in the sources searched. Peptides of this size are generally polar and have low dermal/systemic bioavailability from topical use, so absent data they are treated as no evidence of reproductive hazard (CIR/SCCS absence). Sources searched: ECHA Annex VI (no listing), SCCS/CIR (no opinion), PubMed (no reproductive studies found), PubChem/CosIng (ingredient present but no toxicity/repro data).
Related ingredients
Frequently asked questions
- oligopeptide-55 est-il sûr pendant la grossesse ?
- No harmonised CLP classification, no SCCS or CIR safety assessment specific to oligopeptide-55, and no peer-reviewed reproductive or developmental toxicity data located in the sources searched. Peptides of this size are generally polar and have low dermal/systemic bioavailability from topical use, so absent data they are treated as no evidence of reproductive hazard (CIR/SCCS absence). Sources searched: ECHA Annex VI (no listing), SCCS/CIR (no opinion), PubMed (no reproductive studies found), PubChem/CosIng (ingredient present but no toxicity/repro data).
- oligopeptide-55 est-il sûr pendant l'allaitement ?
- No data indicating lactation transfer or effects on nursing infants. No classifications or published evidence of systemic reproductive/endocrine activity. Given expected low dermal absorption for oligopeptides, systemic exposure to nursing parent is expected to be negligible for typical topical cosmetic use.
- oligopeptide-55 est-il sûr pour la peau de bébé ?
- No evidence of hazard or mechanism specific to infants. Dermal absorption of intact oligopeptides is generally low, but infant skin has immature barrier and higher surface-area-to-weight; therefore exposure (e) is increased by one category relative to adults (adult e=0 → baby e=1) despite no hazard data. No infant-specific studies were found.
- Comment VeriMom évalue-t-il oligopeptide-55 ?
- VeriMom évalue oligopeptide-55 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à oligopeptide-55 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à oligopeptide-55 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.